MKI67 and pancreatic neuroendocrine tumor: Similarly, Weich et al. reported a highly proliferative pancreatic neuroendocrine tumor (Ki67 = 60%) that received four cycles of PRRT after relapse following surgical treatment, leading to partial response [58].